Clinical Benefit, Price, and Uptake for Cancer Biosimilars vs Reference Drugs in ChinaXingxian Luo, Yang Yue, Xufeng Lv et al.|JAMA Network Open|2023Cited by 15
Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in ChinaXingxian Luo, Xiaohong Zhang, Yang Xu et al.|The Lancet Regional Health - Western Pacific|2024Cited by 1